At the World Vaccine Congress 2023 held in Washington, USA from April 3-6, Bharat Biotech was awarded the Best Production/Process Development award as a part of the Vaccine Industry Excellence (ViE) awards.
Bharat Biotech, headquartered in Hyderabad, was the sole Indian company among the nominees for the VIE awards in multiple categories such as the best clinical trial company, best clinical trial network, best central/specialty laboratory, best contract research organisation, and best production/process development, among others. Bharat Biotech is known for developing the world’s first intranasal Covid-19 vaccine, iNcovacc, and its intramuscular vaccine, Covaxin, which is used in India’s public vaccination programme and has also been exported.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The World Vaccine Congress is a major international conference focused on vaccines, covering the entire vaccine value chain from basic research to commercial manufacturing. It brings together experts from all over the world to share their knowledge and expertise in vaccine development. The conference has been particularly important in addressing the COVID-19 pandemic and has been a platform for sharing groundbreaking discoveries and insights.
Important takeaways for all competitive exams:
The Gujarat Chief Minister Bhupendra Patel has made an announcement about awarding the Vishisht Gujarat…
Reserve Bank of India has granted approval for the appointment of Anup Kumar Saha as…
Governor Gavin Newsom has approved the Assembly Bill 1267 (AB 1267), which bans child marriage…
The manufacturing sector in India saw a pick-up in September 2026, as the HSBC India…
Narendra Bhooshan, who is the 1992-batch of Indian Administrative Service (IAS) from the Uttar Pradesh…
Indian batsman Rohit Sharma crossed the 12,000 ODI runs mark in the second ODI match…